Dear Friends of the Fund,
We are sending our Q1 2024 investor letter a bit later than usual for your review. As a result, this is an abbreviated letter which simply reviews the portfolio’s performance, changes to the portfolio in the quarter, as well as reviewing the portfolio’s key attributes. We will resume our regular programming with insights into our investment thinking as well as a deep dive Quality Compounder stock review in our upcoming Q2 2024 investor letter, as we normally do.
As a reminder, Qualivian reached its six year mark in December of 2023. We are actively weighing investment proposals.
Please refer to our investor letter below for our performance and commentary on the first quarter of 2024.
A fact sheet is...
Login required to continue reading.
Setup a free account to get access to this article (no credit card required).
View Full Article
